Premium
Angiogenic activity by spleen cell supernatants from tumor‐bearing and tumor‐resected mice
Author(s) -
Davel Lilia,
Miguez Marta,
Jasnis María Adela,
Eiján Ana María,
OisgoldDagá Sara,
De Lustig Eugenia Sacerdote
Publication year - 1988
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930370113
Subject(s) - spleen , angiogenesis , immune system , lymphokine , in vivo , medicine , cancer research , tumor microenvironment , neovascularization , pathology , lymphocyte , immunology , biology , microbiology and biotechnology
Supernatants of cultured spleen cells (SCS) from small tumor‐bearing mice (STBM) and large tumor‐bearing mice (LTBM) are able to enhance tumor growth as well as accelerate tumor takes in vivo when inoculated 24 h before tumor implant. After tumor resection enhancing activity disappears at a rate depending on the size of the resected tumor. Spleen cells from tumor‐bearing mice also evoke a complex vascular response, lymphocyte‐induced angiogenesis (LIA) elicited via the release of lymphokines from activated T cells. As angiogenic factors promote tumor development we investigated if SCS from tumor‐bearing and tumor‐resected mice contain factors capable of evoking a LIA response. Angiogenic activity was detected by SCS of small and large tumor‐bearing mice as well as in large tumor‐resected mice. On the other hand, SCS from small tumor‐resected mice are not able to evoke an angiogenic response. Possibly, the large antigenic burden in LTRM stimulate the immune system in a different way than in STRM. We can suggest that the different behavior of spleen cells after small and large tumor removal can be explained by quantitative or qualitative changes in the spleen subpopulations.